Evolocumab: Considerations for the Management of Hyperlipidemia

Wiggins, BS; Senfield, J; Kassahun, H; Lira, A; Somaratne, R

Wiggins, BS (reprint author), Med Univ South Carolina, Dept Pharmaceut Sci, Pharm Clin Specialist Cardiol, Charleston, SC 29425 USA.

CURRENT ATHEROSCLEROSIS REPORTS, 2018; 20 (4):

Abstract

Purpose of Review To review the efficacy, safety, pharmacology, and pharmacokinetics of evolocumab, a proprotein convertase subtilisin/kexin type 9 (P......

Full Text Link